Take a look at how to shore up those international supply chain needs, the potential of interstate commerce under state-implemented Memoranda of Understanding, and the future of supply chain consistency in a post-legalized world.
In any industry, M&A is challenging. In cannabis, the issues can be even more complex. This deeper dive panel will focus on five of the most difficult legal issues to manage in these transactions.
Join us for a discussion of the most important aspects of corporate governance, and how we can learn from some of the high profile failures in the industry.
Panelists will discuss how cannabis use and substance abuse issues can interfere with an attorney’s competence obligations, and mandatory reporting requirements.
Niall will discuss cannabis jurisdiction, legislation, regulation, Medical Cannabis Access Programme (MCAP, the Specified Controlled Drugs (Cannabis-Based Medical Products), indications, CBD - Novel Foods (Conflict of Laws), and adult use in the Republic of Ireland.
With the 2018 Farm Bill well under our belts, and implementation of the USDA Rules well underway, let’s take a look at how the world is changing under the new regime. The sunset of the old administrative regimes left over from the 2014 Farm Bill and the rise of the 2018 Farm Bill regulations have created a new way to navigate the hemp industry. Join us to take a look at the terrain ahead.
With legalization initiatives moving quickly in the Tri-State Area, prospective operators are gearing up for what will inevitably be a competitive licensing process. In this session, attorneys will delve into the laws in: New Jersey, New York, and Connecticut.
This CLE explores whether a mark owner has used its mark to sell improperly labeled soap or an illicit drug, the PTO has no mandate, and no convincing policy reason, to deny the owner the substantial benefits of registration.